Celsion Initiates First International Licensing Deal With Japan’s Yakult For Liver Cancer Drug ThermoDox
This article was originally published in PharmAsia News
Executive Summary
TOKYO -Yakult Honsha Co. of Tokyo and Celsion of Columbia, Md., announced a licensing agreement for Celsion's liver cancer drug ThermoDox, marking Celsion's first international licensing deal